Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Novonesis (GB:0Q4U)
LSE:0Q4U
Holding GB:0Q4U?
Track your performance easily
0Q4U Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr344.90 - kr485.60
Previous CloseN/A
Volume19.32K
Average Volume (3M)140.12K
Market Cap
kr187.43B
Enterprise ValueN/A
Total Cash (Recent Filing)$816.00M
Total Debt (Recent Filing)$1.71B
Price to Earnings (P/E)37.0
Beta0.80
Next Earnings
Feb 26, 2025EPS Estimate
3.87Last Dividend Ex-Date
Aug 30, 2024Dividend Yield0.99%
Share Statistics
EPS (TTM)10.91
Shares Outstanding414,555,050
10 Day Avg. Volume12,436
30 Day Avg. Volume140,119
Standard Deviation0.07
R-Squared0.06
Alpha0.00670
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.64
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr477.00Price Target Upside17.20% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Novonesis News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
6.18% Mutual Funds
0.02% Other Institutional Investors
86.04% Public Companies and
Individual Investors
0Q4U FAQ
What was Novonesis’s price range in the past 12 months?
Novonesis lowest share price was kr344.90 and its highest was kr485.60 in the past 12 months.
What is Novonesis’s market cap?
Novonesis’s market cap is kr187.43B.
When is Novonesis’s upcoming earnings report date?
Novonesis’s upcoming earnings report date is Feb 26, 2025 which is in 38 days.
How were Novonesis’s earnings last quarter?
Currently, no data Available
Is Novonesis overvalued?
According to Wall Street analysts Novonesis’s price is currently Undervalued.
Does Novonesis pay dividends?
Novonesis pays a Annually dividend of kr4 which represents an annual dividend yield of 0.99%. See more information on Novonesis dividends here
What is Novonesis’s EPS estimate?
Novonesis’s EPS estimate is 3.87.
How many shares outstanding does Novonesis have?
Novonesis has 414,555,050 shares outstanding.
What happened to Novonesis’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Novonesis?
Currently, no hedge funds are holding shares in GB:0Q4U
---
Company Description
Novonesis
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.
---
0Q4U Revenue Breakdown
28.53% Household Care
24.83% Bioenergy
22.07% Food, Beverages & Human Health
12.82% Grain & Tech Processing
11.75% Agriculture & Animal Health
---
0Q4U Stock 12 Month Forecast
Average Price Target
kr477.00
▲(17.20% Upside)
Technical Analysis
Best Analysts Covering 0Q4U
1 Year
1 Year Success Rate
8/16 ratings generated profit
1 Year Average Return
-3.02%
reiterated a buy rating 2 months ago
Copying Sebastian Bray's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -3.02% per trade.
---